Tejnaksh Healthcare Limited
BSE: TEJNAKSH · Healthcare Service Provider
Limited coverage
We are not actively covering this company or have limited coverage today. Click to request coverage.
Snapshot
Unlock Tejnaksh Healthcare Limited's vital signs
Growth · Profitability · Valuation · Strength · Conviction
Company Overview
Business
Tejnaksh Healthcare Limited is an India-based healthcare provider specialising in urology and nephrology services under the Institute of Urology brand. The company integrates tertiary care hospitals with diagnostic and pharmacy services, while also engaging in medical research and the development of surgical instruments.
Business Model
The company generates revenue through the provision of specialised medical treatments, including kidney stone removal, prostate surgeries, and dialysis. It further diversifies its income streams through diagnostic services, pharmacy operations, and the development of proprietary surgical instruments.
Management Commentary
Management focuses on maintaining a niche specialisation in minimally invasive urological surgeries while expanding the company's geographic footprint across Western India. The firm also prioritises academic medical training and the pursuit of high-volume, complex surgical procedures.
Growth Outlook
Growth is driven by the expansion of the hospital network across Western India and the continued development of innovative surgical technologies. The company aims to leverage its reputation for complex urological procedures to capture a larger market share in the renal care segment.
Key Risks
- Regulatory and Compliance Risk. Healthcare providers are subject to stringent government regulations and licensing requirements that may impact operational costs and expansion plans.
- Concentration Risk. The company's heavy reliance on urology and nephrology services makes it vulnerable to shifts in medical trends or competition within these specific therapeutic areas.
- Geographic Concentration. Operations are primarily concentrated in Maharashtra, exposing the company to regional economic fluctuations and localised healthcare policy changes.
- Talent Retention. The success of specialised medical services depends heavily on the ability to attract and retain highly skilled urologists and medical professionals.
Start your research today
Unlock AI insights, financials, peers and live data on Tejnaksh Healthcare Limited and 5,000+ companies — free.
Peers · Healthcare Service Provider
| Company | Mkt Cap | P/E | EV/EBITDA | Rev Gr YoY | EBITDA Mgn | ROE | ROCE | 1Y Return |
|---|---|---|---|---|---|---|---|---|
Tejnaksh Healthcare LimitedTEJNAKSH | ₹28 Cr | — | — | — | 25.8% | — | — | -24.8% |
Krsnaa Diagnostics Ltd.KRSNAA | ₹1,830 Cr | 18.76 | 8.80 | 10.2% | 32.5% | 10.5% | 13.3% | -28.5% |
Suraksha Diagnostic Ltd.SURAKSHA | ₹1,772 Cr | 48.60 | 16.73 | 22.5% | 32.7% | 15.8% | 18.6% | +14.0% |
3B BlackBio Dx Ltd3BBLACKBIO | ₹1,237 Cr | 20.61 | 14.59 | 41.9% | 58.0% | 21.2% | 26.3% | +0.5% |
One Global Service Provider LimitedONEGLOBAL | ₹1,068 Cr | — | — | — | 19.0% | — | — | +114.9% |
Gaudium IVF and Women Health LimitedGAUDIUMIVF | ₹886 Cr | — | — | — | 36.0% | — | — | — |
As of Mar 2026
Financials
Tejnaksh Healthcare Limited
BSE: TEJNAKSH · Healthcare Service Provider
Limited coverage
We are not actively covering this company or have limited coverage today. Click to request coverage.
Snapshot
Unlock Tejnaksh Healthcare Limited's vital signs
Growth · Profitability · Valuation · Strength · Conviction
Company Overview
Business
Tejnaksh Healthcare Limited is an India-based healthcare provider specialising in urology and nephrology services under the Institute of Urology brand. The company integrates tertiary care hospitals with diagnostic and pharmacy services, while also engaging in medical research and the development of surgical instruments.
Business Model
The company generates revenue through the provision of specialised medical treatments, including kidney stone removal, prostate surgeries, and dialysis. It further diversifies its income streams through diagnostic services, pharmacy operations, and the development of proprietary surgical instruments.
Management Commentary
Management focuses on maintaining a niche specialisation in minimally invasive urological surgeries while expanding the company's geographic footprint across Western India. The firm also prioritises academic medical training and the pursuit of high-volume, complex surgical procedures.
Growth Outlook
Growth is driven by the expansion of the hospital network across Western India and the continued development of innovative surgical technologies. The company aims to leverage its reputation for complex urological procedures to capture a larger market share in the renal care segment.
Key Risks
- Regulatory and Compliance Risk. Healthcare providers are subject to stringent government regulations and licensing requirements that may impact operational costs and expansion plans.
- Concentration Risk. The company's heavy reliance on urology and nephrology services makes it vulnerable to shifts in medical trends or competition within these specific therapeutic areas.
- Geographic Concentration. Operations are primarily concentrated in Maharashtra, exposing the company to regional economic fluctuations and localised healthcare policy changes.
- Talent Retention. The success of specialised medical services depends heavily on the ability to attract and retain highly skilled urologists and medical professionals.
Start your research today
Unlock AI insights, financials, peers and live data on Tejnaksh Healthcare Limited and 5,000+ companies — free.
Peers · Healthcare Service Provider
As of Mar 2026